Hotchkis & Wiley Capital Management LLC Increases Holdings in Utah Medical Products, Inc. $UTMD

Key Points

• Hotchkis & Wiley Capital Management LLC increased its stake in Utah Medical Products, Inc. by 35.2%, owning 101,640 shares valued at approximately $5.7 million as of its latest SEC filing.
• Various hedge funds have also significantly increased their positions in Utah Medical Products, with Tower Research Capital boosting its stake by 172.6%, reflecting a growing institutional interest in the company.
• Utah Medical Products recently announced a quarterly dividend of $0.305 per share, with an annualized dividend yield of 2.0%, indicative of the company's strong profitability with a net margin of 32.34%.

Hotchkis & Wiley Capital Management LLC lifted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 35.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 101,640 shares of the medical instruments supplier's stock after buying an additional 26,460 shares during the period. Hotchkis & Wiley Capital Management LLC owned about 3.10% of Utah Medical Products worth $5,696,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. American Century Companies Inc. boosted its position in shares of Utah Medical Products by 6.8% during the first quarter. American Century Companies Inc. now owns 8,690 shares of the medical instruments supplier's stock valued at $487,000 after buying an additional 555 shares during the last quarter. Nuveen LLC bought a new stake in Utah Medical Products during the first quarter worth $449,000. Invesco Ltd. bought a new stake in Utah Medical Products during the first quarter worth $207,000. Everett Harris & Co. CA lifted its holdings in Utah Medical Products by 327.7% during the first quarter. Everett Harris & Co. CA now owns 17,116 shares of the medical instruments supplier's stock worth $959,000 after acquiring an additional 13,114 shares during the period. Finally, Bard Associates Inc. lifted its holdings in Utah Medical Products by 5.0% during the first quarter. Bard Associates Inc. now owns 21,032 shares of the medical instruments supplier's stock worth $1,185,000 after acquiring an additional 1,002 shares during the period. Hedge funds and other institutional investors own 69.60% of the company's stock.

Utah Medical Products Stock Up 0.2%

Utah Medical Products stock traded up $0.15 during mid-day trading on Friday, reaching $62.21. 12,162 shares of the company's stock were exchanged, compared to its average volume of 14,120. The business's fifty day simple moving average is $57.37 and its 200 day simple moving average is $56.26. The firm has a market capitalization of $199.45 million, a PE ratio of 16.63 and a beta of 0.32. Utah Medical Products, Inc. has a one year low of $51.26 and a one year high of $68.99.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. The business had revenue of $9.95 million for the quarter. Utah Medical Products had a return on equity of 10.55% and a net margin of 32.34%.

Utah Medical Products Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Wednesday, September 17th will be paid a $0.305 dividend. The ex-dividend date is Wednesday, September 17th. This represents a $1.22 annualized dividend and a dividend yield of 2.0%. Utah Medical Products's payout ratio is presently 32.62%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.